Site Members can sign up for company wide alerts
Lawsuit Overview
A shareholder of Indevus Pharmaceuticals Inc (NASDAQ: IDEV) has filed a lawsuit on behalf of investors in Indevus Pharmaceuticals Inc (NASDAQ: IDEV) in effort to prevent its sale to Endo Pharmaceuticals Inc (ENDP.O) for $370 million. The lawsuit alleges that the company and its directors breached their fiduciary duties by agreeing to the offer and merger at an inadequate price Las...
You must register (for free) or login to view the entire case.